New South Capital Management’s Pediatrix Medical MD Stock Holding History

New South Capital Management’s Portfolio MD Stock Details MD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q2	–	Sell	-327,625	Closed	-$8.9M	–	68
2019 Q1	$8.9M	Buy	327,625 +8,345	+3%	+$280K	0.26%	53
2018 Q4	$10.5M	Sell	319,280 -33,583	-10%	-$1.35M	0.34%	50
2018 Q3	$16.5M	Sell	352,863 -36,041	-9%	-$1.65M	0.44%	44
2018 Q2	$16.8M	Sell	388,904 -66,805	-15%	-$3.2M	0.44%	44
2018 Q1	$25.4M	Sell	455,709 -93,467	-17%	-$5.12M	0.63%	37
2017 Q4	$29.3M	Sell	549,176 -55,070	-9%	-$2.6M	0.68%	41
2017 Q3	$26.1M	Sell	604,246 -8,231	-1%	-$391K	0.62%	46
2017 Q2	$37M	Buy	612,477 +2,848	+0.5%	+$169K	0.88%	42
2017 Q1	$42.3M	Sell	609,629 -9,995	-2%	-$694K	0.98%	40
2016 Q4	$41.3M	Buy	619,624 +313,260	+102%	+$20.4M	0.99%	40
2016 Q3	$20.3M	Buy	+306,364	New	+$21M	0.49%	47

Other funds holding MD

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

ACH

ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

PCP

P2 Capital Partners New York $210M AUM 1.23% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fidelity International Hamilton, Bermuda $129B AUM 30.83% 1-Year Est. Return

Lazard Asset Management New York $60.8B AUM 22.47% 1-Year Est. Return

New South Capital Management's MD Position: Q2 2019 in Review

New South Capital Management sold out of Pediatrix Medical (MD) in Q2 2019, closing a stake of 327,625 shares — an estimated $8.9M sold.

New South Capital Management first reported a position in MD in Q3 2016 and held it in 11 quarters. The position peaked at $42.3M in Q1 2017. 247 funds tracked by Wall St. Rank hold MD as of Q2 2019.

New South Capital Management reported no remaining Pediatrix Medical position as of Q2 2019 after selling out during the quarter.
New South Capital Management sold 327,625 Pediatrix Medical shares in Q2 2019, an estimated $8.9M.
New South Capital Management first reported a position in Pediatrix Medical in Q3 2016 and held it in 11 quarters.
New South Capital Management's Pediatrix Medical position peaked at $42.3M in Q1 2017.
247 funds tracked by Wall St. Rank held Pediatrix Medical as of Q2 2019.

Based on New South Capital Management's 13F filing for Q2 2019, filed 13 Aug 2019.